XML 87 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Income taxes
12 Months Ended
Dec. 31, 2021
Income taxes [Abstract]  
Income taxes
16.
Income taxes


The Group recognized less than CHF 0.1 million, nil and nil in income taxes and no deferred tax asset or liability positions for the years ended December 31, 2021, 2020, and 2019, respectively. The Group’s expected tax expense for each year is based on the applicable tax rates in each jurisdiction. In 2021, these rates ranged from 13.6% to 32.9% (13.6% for 2020 and 2019, respectively) in the Group’s respective tax jurisdictions. The weighted average tax rate applicable to the Group was 13.6% (13.6% for 2020 and 2019, respectively). The variance relates to the establishment of AC Immune USA, Inc. in 2021.


The Group’s income tax expense for each year can be reconciled to loss before tax as follows:

   
For the Years Ended
December 31,
 
In CHF thousands
 
2021
   
2020
   
2019
 
Income/(loss) before income tax
   
(72,993
)
   
(61,921
)
   
45,442
 
Tax (benefit)/expense calculated at the domestic rates applicable in the respective countries
   
(9,930
)
   
(8,441
)
   
6,194
 
(Income not subject to tax)/expenses not deductible for tax purposes
   
(375
)
   
462
     
(62
)
Effect of unused tax losses and tax offsets not recognized as deferred tax assets
   
10,308
     
7,979
     
(6,132
)
Effective income tax rate (benefit)/expense
   
3
     
     
 


The Swiss tax rate used for the 2021 reconciliations is the corporate tax rate of 13.6% (13.6% in 2020 and 2019, respectively) payable by corporate entities in the Canton of Vaud, Switzerland on taxable profits under tax law in that jurisdiction.



The below table details the total unrecognized deductible temporary differences, unused tax losses and unused tax credits:

   
As of
December 31,
 
In CHF thousands
 
2021
   
2020
   
2019
 
Unrecognized deductible temporary differences, unused tax losses and unused tax credits
                 
Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:
                 
Tax losses
   
197,152
     
121,948
     
64,125
 
Deductible temporary differences related to:
                       
Right-of-use assets and lease liabilities, net
   
     
     
 
Retirement benefit plan
   
7,098
     
7,464
     
7,485
 
Total
   
204,250
     
129,412
     
71,610
 


The following table details the tax losses carry forwards of the Company and their respective expiry dates:

   
As of
December 31,
 
In CHF thousands
 
2021
   
2020
   
2019
 
Tax losses split by expiry date:
                 
December 31, 2024
   
15,231
     
15,231
     
15,231
 
December 31, 2025
   
48,894
     
48,894
     
48,894
 
December 31, 2026
   
     
     
 
December 31, 2027
   
57,824
     
57,824
     
 
December 31, 2028
    75,204              
Total unrecorded tax loss carryforwards
   
197,153
     
121,949
     
64,125
 


The tax losses available for future offset against taxable profits have increased by CHF 75.2 million from 2020, representing the amount of tax losses that are additionally available as an offset, subject to expiration as disclosed in the table above, against future taxable income.


Consistent with prior years, the Company has not recorded any deferred tax assets in relation to the past tax losses available for offset against future profits as the recognition criteria were not met at the balance sheet date.